A call for transparent reporting to optimize the predictive value of preclinical research

Author(s): Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, et al.

Abstract

The US National Institute of Neurological Disorders and Stroke convened major stakeholders in June 2012 to discuss how to improve the methodological reporting of animal studies in grant applications and publications. The main workshop recommendation is that at a minimum studies should report on sample-size estimation, whether and how animals were randomized, whether investigators were blind to the treatment, and the handling of data. We recognize that achieving a meaningful improvement in the quality of reporting will require a concerted effort by investigators, reviewers, funding agencies and journal editors. Requiring better reporting of animal studies will raise awareness of the importance of rigorous study design to accelerate scientific progress.

Similar Articles

Characterization of a Drosophila Alzheimer's disease model: pharmacological rescue of cognitive defects

Author(s): Chakraborty R, Vepuri V, Mhatre SD, Paddock BE, Miller S, et al.

A conditional tissue-specific transgene expression system using inducible GAL4

Author(s): Osterwalder T, Yoon KS, White BH, Keshishian H

Dementia with Lewy bodies: an emerging disease

Author(s): Neef D1, Walling AD

Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease

Author(s): Van Gool D, De Strooper B, Van Leuven F, Dom R

Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease

Author(s): Harper DG, Stopa EG, McKee AC, Satlin A, Fish D, et al.

4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila

Author(s): Zid BM, Rogers AN, Katewa SD, Vargas MA, Kolipinski MC, et al.